Entero Healthcare Solutions announced robust results for Q4 FY2026, reporting a consolidated net profit of Rs. 451.28 million and revenue of Rs. 19,099.27 million. The company also announced significant growth initiatives, including the acquisition of Vishal Surgicals and Vishal Surgicals & Medicals, and the re-appointment of key independent directors. The company remains focused on its trading operations, emphasizing consolidation and strategic expansion of its subsidiary network.
Financial Highlights
Entero Healthcare Solutions delivered a strong financial performance for the quarter ended March 31, 2026. The consolidated revenue from operations reached Rs. 19,099.27 million, compared to Rs. 13,390.56 million in the same quarter last year. The consolidated profit for the period stood at Rs. 451.28 million. For the full financial year 2026, the company recorded a consolidated annual revenue of Rs. 65,912.12 million and a profit of Rs. 1,458.40 million.
Strategic Acquisitions
The company is expanding its footprint in the pharmaceutical distribution sector through the strategic acquisition of Vishal Surgicals and Vishal Surgicals & Medicals. These partnership firms, based in Khammam and Warangal, Telangana, specialize in the wholesale distribution of pharmaceutical and surgical products. The acquisitions will be executed via a business transfer agreement, with an estimated investment of up to Rs. 63 million and Rs. 29.1 million respectively, to be completed by December 31, 2026.
Board and Operational Updates
The Board of Directors has approved the re-appointment of Mr. Sujesh Vasudevan, Mr. Rajesh Shashikant Dalal, and Ms. Sandhya Gadkari Sharma as Non-Executive Independent Directors for a second term of five years, effective August 25, 2026. Additionally, the company is continuing its commitment to employee incentivization, having granted 7,300 fresh employee stock options and completed the allotment of 7,240 equity shares to eligible employees.
Future Outlook
Entero Healthcare continues to streamline its corporate structure, having received approvals to strike off non-operating subsidiaries. The 8th Annual General Meeting is scheduled to be held on August 19, 2026, via video conferencing, where shareholders will review the company’s annual performance and future strategic directions.
Source: BSE
